Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation

被引:22
作者
Daniel, Jan-Marcus [1 ,2 ]
Prock, Andre [4 ]
Dutzmann, Jochen [1 ]
Sonnenschein, Kristina [1 ,3 ]
Thum, Thomas [2 ,3 ,5 ]
Bauersachs, Johann [1 ,2 ]
Sedding, Daniel G. [1 ,2 ]
机构
[1] Hannover Med Sch, Dept Cardiol & Angiol, Carl Neuberg Str 1, D-30625 Hannover, Germany
[2] Hannover Med Sch, REBIRTH Excellence Cluster, D-30625 Hannover, Germany
[3] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, D-30625 Hannover, Germany
[4] Univ Hosp Wuerzburg, Dept Gen Visceral Vasc & Pediat Surg, Wurzburg, Germany
[5] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England
关键词
neointima; proliferation; signal transduction; vascular remodeling; vascular smooth muscle; END RULE PATHWAY; VASCULAR PROLIFERATION; RGS5; EXPRESSION; GROWTH; ATHEROSCLEROSIS; RESTENOSIS; MICE;
D O I
10.1161/ATVBAHA.115.305974
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Regulator of G-protein signaling 5 (RGS5) is abundantly expressed in vascular smooth muscle cells (SMCs) and inhibits G-protein signaling by enhancing the guanosine triphosphate-hydrolyzing activity of G-subunits. In the present study, we investigated the effects of RGS5 on vascular SMC function in vitro and neointima formation after wire-induced injury in mice and determined the underlying mechanisms. Approach and Results We found a robust expression of RGS5 in native arteries of C57BL/6 mice and a highly significant downregulation within neointimal lesions 10 and 21 days after vascular injury as assessed by quantitative polymerase chain reaction, immunoblotting, and immunohistochemistry. In vitro, RGS5 was found significantly downregulated after mitogenic stimulation of human coronary artery SMCs. To restore RGS5 levels, SMCs were transduced with adenoviral vectors encoding wild-type RGS5 or a nondegradable mutant. RGS5-WT and, even more prominently, the C2A-RGS5 mutant prevented SMC proliferation and migration. In contrast, the siRNA-mediated knockdown of RGS5 significantly augmented SMC proliferation. Following overexpression of RGS5, fluorescence-activated cell sorting analysis of propidium iodide-stained cells indicated cell cycle arrest in G0/G1 phase. Mechanistically, inhibition of the phosphorylation of the extracellular signal-regulated kinase 1/2 and mitogen-activated protein kinase downstream signaling was shown to be responsible for the anti-proliferative effect of RGS5. Following wire-induced injury of the femoral artery in C57BL/6 mice, adenoviral-mediated overexpression of RGS5-WT or C2A-RGS5 significantly reduced SMC proliferation and neointima formation in vivo. Conclusions Downregulation of RGS5 is an important prerequisite for SMC proliferation in vitro and in vivo. Therefore, reconstitution of RGS5 levels represents a promising therapeutic option to prevent vascular remodeling processes.
引用
收藏
页码:317 / 327
页数:11
相关论文
共 23 条
[1]   A comparison of aorta and vena cava medial message expression by cDNA array analysis identities a set of 68 consistently differentially expressed genes, all in aortic media [J].
Adams, LD ;
Geary, RL ;
McManus, B ;
Schwartz, SM .
CIRCULATION RESEARCH, 2000, 87 (07) :623-631
[2]   Procontractile G protein-mediated signaling pathways antagonistically regulate smooth muscle differentiation in vascular remodeling [J].
Althoff, Till F. ;
Juarez, Julian Albarran ;
Troidl, Kerstin ;
Tang, Cong ;
Wang, Shengpeng ;
Wirth, Angela ;
Takefuji, Mikito ;
Wettschureck, Nina ;
Offermanns, Stefan .
JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (12) :2277-2290
[3]   RGS5 promotes arterial growth during arteriogenesis [J].
Arnold, Caroline ;
Feldner, Anja ;
Pfisterer, Larissa ;
Hoedebeck, Maren ;
Troidl, Kerstin ;
Genove, Guillem ;
Wieland, Thomas ;
Hecker, Markus ;
Korff, Thomas .
EMBO MOLECULAR MEDICINE, 2014, 6 (08) :1075-1089
[4]   Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells [J].
Bondjers, C ;
Kalén, M ;
Hellström, M ;
Scheidl, SJ ;
Abramsson, A ;
Renner, O ;
Lindahl, P ;
Cho, HS ;
Kehrl, J ;
Betsholtz, C .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (03) :721-729
[5]   Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice [J].
Cheng, Wen-Lin ;
Wang, Pi-Xiao ;
Wang, Tao ;
Zhang, Yan ;
Du, Cheng ;
Li, Hongliang ;
Ji, Yong .
BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (23) :5676-5689
[6]   Molecular basis of restenosis and drug-eluting stents [J].
Costa, MA ;
Simon, DI .
CIRCULATION, 2005, 111 (17) :2257-2273
[7]   Circulating smooth muscle progenitor cells in arterial remodeling [J].
Daniel, Jan-Marcus ;
Sedding, Daniel G. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 50 (02) :273-279
[8]   Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies [J].
Dzau, VJ ;
Braun-Dullaeus, RC ;
Sedding, DG .
NATURE MEDICINE, 2002, 8 (11) :1249-1256
[9]   PDGF-dependent regulation of regulator of G protein signaling-5 expression and vascular smooth muscle cell functionality [J].
Gunaje, Jagadambika J. ;
Bahrami, Arya J. ;
Schwartz, Stephen M. ;
Daum, Guenter ;
Mahoney, William M., Jr. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2011, 301 (02) :C478-C489
[10]   Vascular normalization in Rgs5-deficient tumours promotes immune destruction [J].
Hamzah, Juliana ;
Jugold, Manfred ;
Kiessling, Fabian ;
Rigby, Paul ;
Manzur, Mitali ;
Marti, Hugo H. ;
Rabie, Tamer ;
Kaden, Sylvia ;
Groene, Hermann-Josef ;
Haemmerling, Guenter J. ;
Arnold, Bernd ;
Ganss, Ruth .
NATURE, 2008, 453 (7193) :410-U67